<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="by a high risk of early and severe evolution with" exact="encephalopathy" post="and death in the first 2 y of life"/>
 <result pre="undernutrition, increased risk of infections, and psychological consequences [34]. Maternal" exact="substance abuse," post="leading to HIV infection, can also have a serious"/>
 <result pre="can be theoretically observed in the exposed newborn. Thus, reversible" exact="anemia" post="has been linked to exposure to zidovudine, and hyper-bilirubinemia"/>
 <result pre="the toxicity profiles of the molecules. An increased risk of" exact="cancer" post="associated with in utero exposure to didanosine was thus"/>
 <result pre="cohort of children born to HIV-positive mothers and a national" exact="cancer" post="registry [45]. Fortunately, didanosine – a genotoxic nucleoside analog"/>
 <result pre="SotoEE, Bahado-SinghRO, et alFetal anomalies and long-term effects associated with" exact="substance abuse" post="in pregnancy: a literature review. Am J Perinatol. 2015;32:405–416.25486291"/>
 <result pre="uninfected infants. JAMA. 2011;305:576–584.21304083 [45]HleyhelM, GoujonS, DelteilC, et alRisk of" exact="cancer" post="in children exposed to didanosine in utero. AIDS. 2016;30:1245–1256.26854809"/>
</results>
